|
LSM12 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.237800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.626200E-01 |
| Normal-vs-Stage2 |
8.013400E-01 |
| Normal-vs-Stage3 |
9.627900E-02 |
| Normal-vs-Stage4 |
1.996230E-02 |
| Stage1-vs-Stage2 |
9.993600E-01 |
| Stage1-vs-Stage3 |
5.299500E-02 |
| Stage1-vs-Stage4 |
2.758300E-04 |
| Stage2-vs-Stage3 |
1.657440E-01 |
| Stage2-vs-Stage4 |
1.651780E-02 |
| Stage3-vs-Stage4 |
1.484840E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.522400E-01 |
| Normal-vs-AfricanAmerican |
9.175600E-01 |
| Normal-vs-Asian |
1.948840E-01 |
| Caucasian-vs-AfricanAmerican |
8.785400E-01 |
| Caucasian-vs-Asian |
3.009700E-02 |
| AfricanAmerican-vs-Asian |
4.400200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.932400E-01 |
| Normal-vs-Female |
2.191900E-02 |
| Male-vs-Female |
1.078170E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.038400E-01 |
| Normal-vs-Extreme_Weight |
5.521800E-01 |
| Normal-vs-Obese |
8.909200E-01 |
| Normal-vs-Extreme_Obese |
4.202800E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.187800E-01 |
| Normal_Weight-vs-Obese |
8.042400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.058800E-01 |
| Extreme_Weight-vs-Obese |
5.314400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.458000E-01 |
| Obese-vs-Extreme_Obese |
5.588600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.750900E-04 |
| Normal-vs-Age(41-60Yrs) |
3.756400E-02 |
| Normal-vs-Age(61-80Yrs) |
4.363800E-02 |
| Normal-vs-Age(81-100Yrs) |
2.992000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.040450E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.77089999944913E-07 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.89680000000681E-05 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.90169999999745E-05 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.000100E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.637900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.825400E-01 |
| Normal-VS-Type2 PRCC |
5.206600E-01 |
| Normal-VS-KIRP CIMP |
1.71169967089213E-10 |
| Normal-VS-Unclassified PRCC |
5.472200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.320800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.45630002185749E-09 |
| Type1 PRCC-VS-Unclassified PRCC |
6.543800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.60039999999029E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
9.990400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.34359999967882E-07 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.213200E-01 |
| Normal-vs-N1 |
4.383600E-03 |
| Normal-vs-N2 |
1.300060E-02 |
| N0-vs-N1 |
3.860200E-03 |
| N0-vs-N2 |
1.504230E-01 |
| N1-vs-N2 |
7.329600E-01 |
|
|
